- €1.59bn
- €1.70bn
- €781.43m
- 30
- 32
- 11
- 12
Annual income statement for Evotec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 446 | 501 | 618 | 751 | 781 |
| Cost of Revenue | |||||
| Gross Profit | 133 | 126 | 152 | 174 | 175 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 384 | 452 | 589 | 725 | 829 |
| Operating Profit | 62.6 | 48.6 | 29.1 | 26.6 | -47.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 56.6 | 25.8 | 237 | -154 | -80.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 37.2 | 6.28 | 216 | -176 | -83.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 38.1 | 6.28 | 216 | -176 | -83.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 38.1 | 6.28 | 216 | -176 | -83.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.307 | 0.055 | 1.36 | -1.02 | -0.456 |
| Dividends per Share |